Abbott India EV/EBIT
Cos'è EV/EBIT di Abbott India?
EV/EBIT di Abbott India Limited è 39.90
Qual è la definizione di EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT di aziende nel Health Care settore su BSE rispetto a Abbott India
Cosa fa Abbott India?
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolics, central nervous system, pain management, nutritional supplements, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was founded in 1944 and is headquartered in Mumbai, India. Abbott India Limited operates as a subsidiary of Abbott Laboratories
Aziende con ev/ebit simili a Abbott India
- CAST SA ha EV/EBIT di 39.82
- Lonza AG ha EV/EBIT di 39.83
- Zenith Healthcare ha EV/EBIT di 39.87
- CR Constr Grp Hldg Ltd ha EV/EBIT di 39.88
- Terreno Realty Corp ha EV/EBIT di 39.89
- Tiffany & Co ha EV/EBIT di 39.90
- Abbott India ha EV/EBIT di 39.90
- Neogen Chemicals ha EV/EBIT di 39.92
- The Bombay Dyeing and Manufacturing ha EV/EBIT di 39.94
- GHP Noetic Science-Psychedelic Pharma ha EV/EBIT di 39.95
- N.B.I. Industrial Finance ha EV/EBIT di 39.95
- Texmaco Rail & Engineering ha EV/EBIT di 39.96
- Shift4 Payments ha EV/EBIT di 39.97